Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection
Conclusion: These data suggest the high potential of 5c3c-derived IL-21-expressing rHBV as a novel therapeutic against chronic HBV infection.
Source: Theranostics - Category: Molecular Biology Authors: Zhongliang Shen, Jingwen Wu, Zixiang Gao, Jingyu Wang, Haoxiang Zhu, Richen Mao, Xuanyi Wang, Jiming Zhang, Youhua Xie, Jing Liu Tags: Research Paper Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Genetics | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Molecular Biology | Urology & Nephrology